Leukemia Therapeutics

Manufacturing · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

48 Valley Beach Ave Apt 4, Hull, Massach...

Phone Number

(617) 378-5476

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Leukemia Therapeutics

Leukemia Therapeutics is dedicated to accelerating the discovery of novel, antibody-targeted drug therapies aimed at improving the survival and quality of life for leukemia patients. The company operates as an active partner in the open science ecosystem, merging academic medicine with pharmaceutical expertise. Their focus includes treatments for various types of leukemia, such as Acute Myeloid Leukemia, Hairy Cell Leukemia, and Adult T-Cell Leukemia. Based in Boston, MA, they are committed to driving innovation in leukemia therapeutics.Explore more
Leukemia Therapeutics's Social MediaPopular SearchesLeukemia Therapeutics LLCcleveland leukemia therapeutics LLCLeukemiatherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Leukemia Therapeutics Org Chart

CS
United States flag for contact location.

Chief Executive Officer

PhoneEmail

Is Leukemia Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Leukemia Therapeutics

Compare insights from companies similar to Leukemia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Leukemia Therapeutics

<$5M
1-10
Private
-
2008
$11.1M
11-50
Private
<$5M
2005
Patty Ferrante, Chief Operating Officer at Melior Discovery
Patty FerranteChief Operating Officer
<$5M
1-10
Private
-
2019
Xuelian Zhao, Founder & Chief Executive Officer at EliteImmune
Xuelian ZhaoFounder & CEO
<$5M
11-50
Private
-
2009
N/A
<$5M
11-50
Private
-
2018
JS
Jane SeagalSenior Vice President
<$5M
11-50
Private
-
2015
11-50
Public
$199.6M
1996
James Caruso, President, Chief Executive Officer & Director at Cellectar Biosciences
James CarusoPresident, CEO & Director
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Leukemia Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Leukemia Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Leukemia Therapeutics.

Leukemia Therapeutics Tech Stack

A closer look at the technologies used by Leukemia Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Leukemia Therapeutics

What is Leukemia Therapeutics's official website?
Leukemia Therapeutics's official website is www.leukemiatherapeutics.com
What is Leukemia Therapeutics's Revenue?
Leukemia Therapeutics's revenue is <$5 Million
What is Leukemia Therapeutics's SIC code?
Leukemia Therapeutics's SIC: 28,283
What is Leukemia Therapeutics's NAICS code?
Leukemia Therapeutics's NAICS: 32,325
How many employees does Leukemia Therapeutics have?
Leukemia Therapeutics has 1-10 employees
What industry does Leukemia Therapeutics belong to?
Leukemia Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Leukemia Therapeutics competition?
Leukemia Therapeutics top competitors include: Melior Discovery, Revitope Oncology, AlivaMab Biologics, Cellectar Biosciences
What technology does Leukemia Therapeutics use?
Some of the popular technologies that Leukemia Therapeutics uses are: WordPress.org, PHP, Google Font API, Font Awesome
How do I contact Leukemia Therapeutics?
Leukemia Therapeutics contact info: Phone number: (617) 378-5476 Website: www.leukemiatherapeutics.com
What does Leukemia Therapeutics do?

Leukemia Therapeutics is dedicated to accelerating the discovery of novel, antibody-targeted drug therapies aimed at improving the survival and quality of life for leukemia patients. The company operates as an active partner in the open science ecosystem, merging academic medicine with pharmaceutical expertise. Their focus includes treatments for v... arious types of leukemia, such as Acute Myeloid Leukemia, Hairy Cell Leukemia, and Adult T-Cell Leukemia. Based in Boston, MA, they are committed to driving innovation in leukemia therapeutics.Read More

What are Leukemia Therapeutics social media links?
Leukemia Therapeutics Linkedin page
Is Leukemia Therapeutics a public company?
Leukemia Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Leukemia Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.